VP Watchlist
The VP Watchlist contains current coverage companies that deserve consideration for short term and long term portfolio additions.
Latest News
Decoy20 represents a novel approach to cancer immunotherapy. Unlike current treatments that target specific immune pathways, Decoy20 aims to activate a broad antitumor response from both innate and ad...
Read MoreThe global diabetes care market, valued at $18.9 billion in 2023, is projected to reach $35.8 billion by 2028, with the insulin pump segment expected to grow from $5.26 billion to $21.65 bil...
Read MoreGet ready for a week of financial fireworks as the stock market's version of a reality TV show unfolds! First up on the stage is the chip-making superstar, Nvidia (NVDA), set to drop its earnings repo...
Read MoreVista Research
Blog & Newsletters
Exclusive daily market recaps & stories, weekly market views, and macroeconomic and investment newsletters help investors to stay current with real-time market coverage that is sent FREE directly to all that are in the Vista Network.
Learn MoreInterviews
"Vista’s “Interviews Page” provides consolidated access to our sister organization Tribe Public’s Presentation and Q&A Event Webinar Series & other exciting interviews from other organizations that we would like to highlight from around the world."
Learn More